Provides ordinary whole life insurance policies. Offers endowment policies to non-U.S. residents. Now — the numbers.
This is an established company with proven profits.
The market pays 12.4× for every dollar of annual profit — cheap, which is either an opportunity or a warning.
Against companies in its own sector, it looks cheaper than 77% of them.
Analysts' average target sits 3% above today's price.
Executives buying with their own money is usually read as confidence in the company’s future.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
For a bank, strength is measured by capital buffers and reserves — not cash minus debt.
Clearly above the class average — a step short of the very top.
Clearly below the class average.
Clearly below the class average.
Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.
Growth: Sales growth trails the sector average.
The stock trades 48% below its peak. The market has trimmed its expectations for the company.
Over the last 12 months, company executives reported 81 buys and 43 sells. Management buying with its own money is usually read as a good sign.
Over the last 4 years, sales grew only 1% a year on average. At this size, speeding back up is not easy.
Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 2/100. For a turnaround signal, the stock first needs to close the gap with the market.
The growth engine is running at low revs right now. Report-card grade: 33/100.
On our five-subject report card, CIA sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: CIA does earn real profits — but on our report card it still sits behind its class. The real debate here isn’t the price — it’s whether the company can keep up this pace.
Not covered, because the filings we hold do not carry it: the revenue breakdown.